Published in G Ital Med Lav Ergon on April 15, 2008
Hydrocarbon exposure and Parkinson's disease. Neurology (2000) 1.70
Partition coefficients of some industrial aliphatic hydrocarbons (C5-C7) in blood and human tissues. Br J Ind Med (1985) 1.32
Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system. Hum Mol Genet (1997) 1.28
GABAB receptor protein and mRNA distribution in rat spinal cord and dorsal root ganglia. Eur J Neurosci (2000) 1.27
Solvent exposure in a shoe upper factory. Int Arch Occup Environ Health (1978) 1.16
Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure. Br J Ind Med (1981) 1.15
Urinary excretion of n-hexane metabolites in rats and humans. Int Arch Occup Environ Health (1979) 1.10
Toluene concentrations in the blood and alveolar air of workers during the workshift and the morning after. Br J Ind Med (1986) 1.03
Biomonitoring of industrial solvent exposures in workers' alveolar air. Int Arch Occup Environ Health (1980) 1.02
Methyl ethyl ketone exposure in industrial workers. Uptake and kinetics. Int Arch Occup Environ Health (1984) 0.99
Alveolar air and blood dichloromethane concentration in shoe sole factory workers. Int Arch Occup Environ Health (1977) 0.99
Reference values for blood benzene in the occupationally unexposed general population. Int Arch Occup Environ Health (1992) 0.99
Identification of the metabolites of n-hexane, cyclohexane, and their isomers in men's urine. Toxicol Appl Pharmacol (1980) 0.97
Benzene in the blood and breath of normal people and occupationally exposed workers. Am J Ind Med (1989) 0.97
Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Commun Mass Spectrom (1998) 0.97
Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey. Arch Toxicol (1982) 0.95
Solvent exposure in a shoe upper factory. II. Methylcyclopentane, 2-methylpentane, and 3-methylpentane concentration in alveolar and in environmental air and in blood. Int Arch Occup Environ Health (1979) 0.94
Lung uptake and metabolism of cyclohexane in shoe factory workers. Int Arch Occup Environ Health (1980) 0.94
Generation of a selective 5-HT3B subunit-recognising polyclonal antibody; identification of immunoreactive cells in rat hippocampus. Neuropharmacology (2001) 0.93
[2,5-hexanedione in biological monitoring of occupational exposure to n-hexane]. Med Lav (1985) 0.93
Experimental neurotoxicity and urinary metabolites of the C5-C7 aliphatic hydrocarbons used as glue solvents in shoe manufacture. Clin Toxicol (1981) 0.92
The Gene-Environment Interactions in Respiratory Diseases (GEIRD) Project. Int Arch Allergy Immunol (2010) 0.92
The validity of urinary metabolites as indicators of low exposures to toluene. Int Arch Occup Environ Health (1985) 0.90
Measurement of the urinary metabolites of N-hexane, cyclohexane and their isomers by gas chromatography. Int Arch Occup Environ Health (1981) 0.90
Biomonitoring of occupational toluene exposure. Int Arch Occup Environ Health (1982) 0.90
Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine. Br J Ind Med (1986) 0.88
[Sudden death caused by freon 22?]. Med Lav (1993) 0.88
Benzene in blood as a biomarker of low level occupational exposure. Sci Total Environ (1999) 0.86
[Gas chromatographic determination of 2,5-hexanedione in the urine]. Med Lav (1987) 0.86
Breath and blood levels of benzene, toluene, cumene and styrene in non-occupational exposure. Int Arch Occup Environ Health (1989) 0.86
Biological monitoring of workers exposed to N-N-dimethylformamide. II. Dimethylformamide and its metabolites in urine of exposed workers. Int Arch Occup Environ Health (1995) 0.85
Alveolar air and blood toluene concentration in rotogravure workers. Int Arch Occup Environ Health (1976) 0.85
Ethylene oxide exposure. Biological monitoring by analysis of alveolar air and blood. Int Arch Occup Environ Health (1986) 0.85
Metabolic interaction between n-hexane and toluene in vivo and in vitro. Int Arch Occup Environ Health (1982) 0.85
Decline of blood and alveolar toluene concentration following two accidental human poisonings. Int Arch Occup Environ Health (1983) 0.84
Poor metabolization of n-hexane in Parkinson's disease. J Neurol (2003) 0.83
Benzene in environmental air and human blood. Int Arch Occup Environ Health (1998) 0.83
Biological monitoring of occupational exposure to N,N-dimethylacetamide with identification of a new metabolite. Occup Environ Med (2003) 0.83
Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry. Rapid Commun Mass Spectrom (1998) 0.83
Blood toluene as a biological index of environmental toluene exposure in the "normal" population and in occupationally exposed workers immediately after exposure and 16 hours later. Int Arch Occup Environ Health (1995) 0.82
Hippuric acid and ortho-cresol as biological indicators of occupational exposure to toluene. Am J Ind Med (1987) 0.82
Blood styrene concentrations in a "normal" population and in exposed workers 16 hours after the end of the workshift. Int Arch Occup Environ Health (1993) 0.82
Nitrous oxide in blood and urine of operating theatre personnel and the general population. Int Arch Occup Environ Health (1995) 0.82
Neurotoxic metabolites of "commercial hexane" in the urine of shoe factory workers. Clin Toxicol (1981) 0.81
Blood and urine concentrations of chemical pollutants in the general population. Med Lav (1995) 0.81
A reticuloreticular commissural pathway in the rat thalamus. J Comp Neurol (1994) 0.81
Is hymenoptera venom allergy an occupational disease? Occup Environ Med (2008) 0.81
Biological monitoring of styrene exposure and possible interference of acetone co-exposure. Int Arch Occup Environ Health (1997) 0.81
Clinical and pathological features in hydrocarbon-induced parkinsonism. Ann Neurol (1996) 0.81
Biological monitoring in occupational exposure to low levels of 1,3-butadiene. Toxicol Lett (2004) 0.80
[Peripheral neuropathy caused by incongruous posture in shoe manufacture workers]. Med Lav (1989) 0.80
[Environmental exposure and blood levels of benzene in gas station attendants. Comparison with the general population]. Med Lav (1997) 0.80
Concentration of ethylene oxide in the alveolar air of occupationally exposed workers. Am J Ind Med (1985) 0.79
Reference values for blood toluene in the occupationally nonexposed general population. Int Arch Occup Environ Health (1993) 0.79
Effects of postnatal or adult chronic acetylcholinesterase inhibition on muscarinic receptors, phosphoinositide turnover and m1 mRNA expression. Eur J Pharmacol (1993) 0.79
Identification of the n-heptane metabolites in rat and human urine. Arch Toxicol (1986) 0.79
Use of computerized digital thermometry for diagnosis of Raynaud's phenomenon. Angiology (1989) 0.78
Biological monitoring of occupational exposure to n-hexane by measurement of urinary 2,5-hexanedione. Int Arch Occup Environ Health (1993) 0.78
n-Hexane-induced parkinsonism: pathogenetic hypotheses. Mov Disord (1995) 0.78
Exposure to mutagenic airborne particulate in a rubber manufacturing plant. Mutat Res (1999) 0.78
Determination of urinary 2,5-hexanedione in the general Italian population. Int Arch Occup Environ Health (1998) 0.78
[Coma caused by probably accidental ingestion of xylene: treatment with hemoperfusion using activated charcoal]. Med Lav (1985) 0.78
N-N-dimethylformamide concentration in environmental and alveolar air in an artificial leather factory. Br J Ind Med (1980) 0.78
Acetone-induced changes in the toxicokinetics of 2,5-hexanedione in rabbits. Scand J Work Environ Health (1986) 0.77
Xenobiotic action on steroid hormone synthesis and sulfonation the example of lead and polychlorinated biphenyls. Int Arch Occup Environ Health (2008) 0.77
Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma. Respiration (2000) 0.77
Isopropanol exposure: environmental and biological monitoring in a printing works. Br J Ind Med (1983) 0.77
An experimental study on the neurotoxicity of n-hexane metabolites: hexanol-1 and hexanol-2. Toxicol Appl Pharmacol (1978) 0.77
[Effects of cigarette smoking on blood and alveolar air levels of benzene]. Med Lav (1991) 0.77
[Computerized thermometry and skin esthesiometry of the hands in the diagnosis of peripheral vascular disease due to vibrating tools]. Med Lav (1985) 0.77
Occupational exposure to solvents: field comparison of active and passive samplers and biological monitoring of exposed workers. Ann Occup Hyg (1986) 0.76
[Occupational exposure to technical hexane: a study of its biotransformation products detectable in the urine]. Ann Ist Super Sanita (1981) 0.76
Omalizumab in persistent severe bakers' asthma. Allergy (2008) 0.76
[Alveolar air as an index of exposure to solvents]. Ann Ist Super Sanita (1981) 0.75
[Alveolar air in the monitoring of occupational exposure to volatile chemical compounds]. Med Lav (1983) 0.75
[Determination of industrially used solvents in blood, alveolar air and urine in a group of blood donors]. Med Lav (1989) 0.75
[Risk assessment concerning hospital personnel participating in the preparation and administration of antineoplastic drugs]. G Ital Med Lav Ergon (2000) 0.75
[Disseminated intravascular coagulation (DIC) caused by 1,2-dichloropropane (commercial trielin). Description of 2 cases]. Med Lav (1986) 0.75
[Proposal for threshold limit values for organic solvent concentrations in alveolar air]. Ann Ist Super Sanita (1978) 0.75
[Proposal for a new method of thermal desorption of solvents from passive personal samplers]. G Ital Med Lav (1983) 0.75
Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon. Angiology (1989) 0.75
[Follow up of person-related bullying and work-related bullying: evaluation of effectiveness of interventions]. G Ital Med Lav Ergon (2008) 0.75
Interethnic differences at the thermometric response to cold test: functional disorders of blood circulation in hand fingers and exposure to hand-arm vibration. Int Arch Occup Environ Health (2007) 0.75
[New biomarkers of exposure]. G Ital Med Lav Ergon (2004) 0.75
Toluene coma and liver function. Scand J Work Environ Health (1985) 0.75
Effects of acute n-hexane and 2,5-hexanedione treatment on the striatal dopaminergic system in mice. J Neural Transm Suppl (1995) 0.75
Monitoring of industrial exposure to dimethylformamide by analysis of alveolar air. G Ital Med Lav (1985) 0.75
Biological monitoring of occupational exposure to cyclohexane by urinary 1,2- and 1,4-cyclohexanediol determination. Int Arch Occup Environ Health (1999) 0.75
Purge and Trap analysis of toluene in blood: comparison with the Head Space method. Am Ind Hyg Assoc J (1982) 0.75
[Environmental pollution by the solvents in shoe factories]. Ann Ist Super Sanita (1981) 0.75
[Prevalence of occupational allergic symptoms among bakers of Verona]. G Ital Med Lav Ergon (2008) 0.75
[Chrono-thermometry in the diagnosis of Raynaud-like vasculopathies caused by prolonged use of vibrating tools]. Med Lav (1999) 0.75
Occupational styrene exposure: environmental and biological monitoring. Am J Ind Med (1983) 0.75
[Guidelines for assessment and management of risks caused by benzene for workers at gas stations]. G Ital Med Lav Ergon (2001) 0.75
[The determination of urinary cyclophosphamide at low concentration levels by liquid-liquid extraction and HPLC/MS/MS analysis]. G Ital Med Lav Ergon (1999) 0.75
[Reference values of solvents and metabolites in biological samples]. G Ital Med Lav Ergon (2003) 0.75
[Occupational arsine poisoning: description of a case]. Med Lav (1990) 0.75
Monitoring of occupational exposure to low concentration of carbon tetrachloride. Dev Toxicol Environ Sci (1983) 0.75
Environmental and biological monitoring of occupational methylethyl ketone exposure. Dev Toxicol Environ Sci (1983) 0.75